Get the Stockscreener App
452.77
0.02%
-0.09
After Hours:
452.77
Idexx Laboratories Inc stock is traded at $452.77, with a volume of 677.24K.
It is down -0.02% in the last 24 hours and up +5.95% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$452.86
Open:
$454.41
24h Volume:
677.24K
Relative Volume:
1.11
Market Cap:
$37.07B
Revenue:
$3.90B
Net Income/Loss:
$887.87M
P/E Ratio:
42.43
EPS:
10.67
Net Cash Flow:
$808.08M
1W Performance:
+1.85%
1M Performance:
+5.95%
6M Performance:
-8.53%
1Y Performance:
-18.39%
1-Day Range:
$452.46
$460.38
1-Week Range:
$440.99
$460.38
52-Week Range:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Bought by Truist Financial Corp - MarketBeat
Allworth Financial LP Raises Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX LABORATORIES INC /DE SEC 10-K Report - TradingView
Flossbach Von Storch SE Raises Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Principal Financial Group Inc. Lowers Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Rhumbline Advisers Cuts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Villere ST Denis J & Co. LLC Acquires 1,556 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Alberta Investment Management Corp Boosts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
New York State Teachers Retirement System Trims Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Asset Management One Co. Ltd. Buys 3,057 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
TimesSquare Capital Management LLC Buys 46,857 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Chevy Chase Trust Holdings LLC Has $17.79 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
CIBC Asset Management Inc Has $10.90 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Should You Hold IDEXX Stock in Your Portfolio for Now? - Nasdaq
Waycross Partners LLC Takes Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Congress Asset Management Co. - MarketBeat
IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know - MSN
Should You Invest in IDEXX Laboratories (IDXX)? - MSN
Blue Zone Wealth Advisors LLC Takes $3.96 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Pittenger & Anderson Inc. Sells 16,496 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by WD Rutherford LLC - MarketBeat
George Fennell Sells 9,986 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - MarketBeat
Adell Harriman & Carpenter Inc. Invests $413,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Fiera Capital Corp - MarketBeat
Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX) Price Target at $533.75 - MarketBeat
CFC Planning Co LLC Purchases New Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Equitable Trust Co. Invests $676,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Position Increased by Vontobel Holding Ltd. - MarketBeat
IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients - MSN
Moloney Securities Asset Management LLC Purchases New Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Raised by Marks Group Wealth Management Inc - MarketBeat
IDEXX Laboratories Announces Board Resignation - MSN
IDEXX Laboratories Announces Board Resignation By Investing.com - Investing.com South Africa
Idexx Laboratories Director Resigns, Board Size Reduced - TipRanks
M Anne Szostak Sells 3,000 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - MarketBeat
Thompson Investment Management Inc. Takes $310,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Apollon Wealth Management LLC Sells 2,027 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Piper Sandler Increases IDEXX Laboratories (NASDAQ:IDXX) Price Target to $510.00 - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $82.05 Million Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Fund Update: COMGEST GLOBAL INVESTORS S.A.S. added 145,203 shares of IDEXX LABS ($IDXX) to their portfolio - Nasdaq
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - Business Wire
Entropy Technologies LP Has $2.27 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Why Idexx Labs Stock Rocketed Higher This Week - AOL
Options Movement At IDEXX Laboratories: Michael G Erickson Exercises Worth $597K - Benzinga
This Pet Healthcare Stock Is Booming – And It Still Looks Undervalued - Finimize
State of Alaska Department of Revenue Sells 1,986 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories executive vice president sells $4.6 million in stock - MSN
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.04%
0.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):